TaeWoong Medical has secured the US FDA clearance to commercialise the Niti-S Spaxus Stent, expanding its range of EUS-guided therapeutic solutions.

New research shows that palliative patients with pancreatic cancer neither live longer nor experience improved quality of ...

The U.S. Food and Drug Administration (FDA) has granted expanded access for the use of an experimental pancreatic cancer drug ...

A man who lost over 80 pounds before nearly losing his life is sharing his story as a cautionary tale for others seeking ...

Reports suggest that Microsoft, one of the industry’s biggest customers, might be taking a step back. Last week, news outlets reported that Microsoft was pausing carbon removal purchases. It was ...

A glimmer of hope may be on the horizon for a ruthless cancer that former Sen. Ben Sasse (R-Neb.) once called a “definite death sentence.” An experimental treatment from Revolution Medicines helped ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Former Senator Ben Sasse has become an unlikely public face of a drug that researchers are ...

Pancreatic cancer is one of the most challenging diseases to treat, and while survival rates have improved since the 1970s, they have plateaued in recent years. But two promising drugs in the pipeline ...

Revolution Medicines’ pan-RAS inhibitor helped patients with a highly aggressive form of pancreatic cancer live an average of six months longer than chemotherapy, hitting a goal of the phase 3 study.

Hyderabad: HYDRA Commissioner AV Ranganath here on Friday suggested that the residential colonies would not flood during monsoon if the silt accumulated in drainage and flood canals is completely ...

Ten personnel from the Grogol Petamburan Water Resources (SDA) Unit, dredged a drainage channel on Jalan Hadiah Utama 1, RT 07/02 in Jelambar. They collected 550 bags of mud, or about 9.1 cubic meters ...